SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

Corvus Pharmaceuticals Q4 EPS $(0.38) Misses $(0.33) Estimate

Corvus Pharmaceuticals (NASDAQ:CRVS) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.33) by 15.15 percent. This is a 5.56 percent decrease over losses of $(0.36) per

Benzinga · 03/05/2020 21:11

Corvus Pharmaceuticals (NASDAQ:CRVS) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.33) by 15.15 percent. This is a 5.56 percent decrease over losses of $(0.36) per share from the same period last year.